Orchid Chemicals Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Orchid Chemicals Quarterly Results    (ORCHID)

Here are the latest quarterly results of Orchid Chemicals. For more details, see the Orchid Chemicals financial fact sheet and Orchid Chemicals share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Orchid Chemicals Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-18
3
Jun-18
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,5581,3061,4251,4851,6211,3581,3101,286 
Other income Rs m1443631945526670 
Turnover Rs m1,5721,3491,4881,5031,6661,4091,3761,356 
Expenses Rs m2,2721,4491,4571,3601,6981,4521,3101,376 
Gross profit Rs m-714-3935125134-940-90 
Depreciation Rs m326328330328313314317316 
Interest Rs m01350000111 
Profit before tax Rs m-1,025-460-231-185-134-356-252-347 
Tax Rs m-1010000000 
Profit after tax Rs m-924-460-231-185-134-356-252-347 
Gross profit margin %-45.8-3.02.58.48.3-6.90.0-7.0 
Effective tax rate %9.90.00.00.00.00.00.00.0 
Net profit margin %-59.3-35.2-16.2-12.4-8.3-26.2-19.2-27.0 
Diluted EPS Rs -10.8 -5.4 -2.7 -2.2 -1.6 -4.2 -3.0 -4.1  
Diluted EPS (TTM) Rs -41.6 -33.5 -28.0 -21.1 -11.9 -10.6 -10.9 -12.8  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Orchid Chemicals 2QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   AJANTA PHARMA  VENUS REMEDIES  PIRAMAL ENTERPRISES  ASTRAZENECA PHARMA  UNICHEM LAB  

Compare ORCHID PHARMA LTD With:   AJANTA PHARMA  VENUS REMEDIES  PIRAMAL ENTERPRISES  ASTRAZENECA PHARMA  UNICHEM LAB  

Compare ORCHID PHARMA LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Lower; Telecom and Metal Stocks Fall(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.6% while the Hang Seng is down 0.6%.

Views on news

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It. (Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

Why India Will Be the Biggest Winner in a Post-Coronavirus World (The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock (Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - VENUS REMEDIES COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS